Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | mesalazine | 2206 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | mesalazine | 2206 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | mesalazine | 2206 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | mesalazine | 2206 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | mesalazine | 2206 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | mesalazine | 2206 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | mesalazine | 2206 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | mesalazine | 2206 | drug-path |
| Basal transcription factors | R-HSA-3232118 | map03022 | mesalazine | 2206 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | mesalazine | 2206 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | mesalazine | 2206 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | mesalazine | 2206 | drug-path |
| Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | mesalazine | 2206 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | mesalazine | 2206 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | mesalazine | 2206 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | mesalazine | 2206 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | hydrastine hydrochloride | 197834 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | hydrastine hydrochloride | 197834 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | hydrastine hydrochloride | 197834 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | hydrastine hydrochloride | 197834 | drug-path |